MiMedx Group Financial Ratios Analysis

Valuation, profitability, leverage, and liquidity ratios

Scroll to see more
BreakdownFY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Valuation Ratios
P/E Ratio33.3321.91
Forward P/E12.6712.6712.6712.6712.67
P/S Ratio4.053.171.182.773.93
P/B Ratio7.327.154.247.2410.68
Price/Tangible Book8.728.65
Price/FCF21.9141.17
Price/OCF21.3538.11
PEG Ratio0.840.840.840.840.84
Enterprise Value Ratios
EV/Revenue3.853.371.463.004.07
EV/EBITDA20.5626.70
EV/EBIT22.6629.17
EV/FCF20.8343.67
Profitability & Returns
Return on Equity (ROE)0.25%0.62%-0.24%-0.13%-0.78%
Return on Assets (ROA)0.15%0.11%-0.05%-0.02%-0.15%
Return on Invested Capital (ROIC)0.39%0.43%-0.25%-0.13%-1.08%
Return on Capital Employed (ROCE)0.27%0.19%-0.12%-0.05%-0.31%
Leverage & Solvency Ratios
Debt/Equity0.130.360.700.580.57
Debt/EBITDA0.371.23
Debt/FCF0.392.08
Liquidity Ratios
Current Ratio4.213.573.083.512.71
Quick Ratio3.522.952.503.032.39
Efficiency Ratios
Asset Turnover1.391.571.491.241.34
Inventory Turnover2.683.193.933.644.04
Yield & Distribution Ratios
Earnings Yield0.03%0.06%-0.10%-0.02%-0.05%
FCF Yield0.05%0.02%-0.06%-0.01%-0.04%
Buyback Yield-0.02%-0.29%-0.02%-0.02%-0.01%